Newly Established Air Purification Company for Sale in Victoria, Canada
Established | 0-1 year(s) |
Employees | 10 - 50 |
Legal Entity | Private Limited Company |
Reported Sales | Nil |
Run Rate Sales | Nil |
EBITDA Margin | Nil |
Industries | Air Purification + 1 more |
Locations | Victoria |
Local Time | 1:49 AM America / Chicago |
Listed By | Management Member |
Status | Active |
- Utilizing advanced technology, our testing ventilation systems effectively remove 99.93% of MRSA, 98.74% of Influenza A, and 99.64% of Streptococcus Pneumonia, reflecting our commitment to superior air purification.
- The systems have achieved certifications from trusted authorities such as the EPA, UL, FCC, and CARB, ensuring full compliance with health and safety standards.
- Our proprietary testing and sterilization equipment rapidly eliminates pathogens like SARS-CoV-2, MRSA, and mold, with initial sterilization times ranging from 60 to 180 minutes. Sustained sterilization further enhances long-term air quality.
- Founded four years ago, the company is built on 11 years of dedicated research in disinfection and sterilization technology, forming a strong foundation in innovation and product development.
- Currently in the pre-revenue stage, the startup is preparing to enter the market by targeting hospitals, industries, and healthcare facilities as primary customers.
- The business model focuses on monetizing this technology through the sale and installation of certified disinfection and sterilization systems, offering long-term value and safety to clients seeking advanced pathogen control.
- As part of the full sale, the buyer will acquire all patents and licenses, enabling them to independently manufacture the equipment and commence operations immediately.
Its advanced technology products include ventilation systems and proprietary testing and sterilization equipment capable of eliminating up to 99.93% of harmful pathogens such as MRSA, Influenza A, Streptococcus Pneumonia, and SARS-CoV-2. Customers utilize these solutions to ensure safer, pathogen-free environments, with the equipment offering rapid initial sterilization and long-term air quality enhancement.
Intangible assets include ownership of IPO of the patented technology, patents and certifications, all valued at CAD 490 million.
There are 10 private shareholders.
No loans or debts.
Ready for acquisition.